Below we provide an update on several ophthalmic anti-VEGF therapeutics currently being studied in clinical trials....more
Big Molecule Watch monitors for biosimilar clinical trial results. Here we report on four recent announcements concerning biosimilars of natalizumab, trastuzumab, daratumumab, and aflibercept....more